By MIKE MAGEE In 1872, English mathematician and sometimes poet, Augustus de Morgan, wrote this catching rhyme: “Great fleas have little fleas upon their backs to bite ‘em, And little fleas have lesser fleas, and so ad infinitum.” This truism about competition among species for access to nutrition and reproduction could have come in handy to…
Boston Scientific disclosed a cyberattack disrupting its global IT systems and order shipping capabilities, with the company unable to provide a timeline for when normal operations will resume. The disclosure adds the medical device giant to a growing list of medtech companies — including Stryker, Medtronic and Abbott — hit by major cyberattacks this year….
A federal judge in July gave digital equity advocates a partial victory against President Donald Trump, stopping his attempt to unilaterally kill a multibillion-dollar grant program Congress created. But U.S. District Judge John D. Bates, in a 35-page opinion, also agreed with the administration that it was unconstitutional for the government to use race or…
By reducing the time spent on administrative tasks, AI scribes allow physicians to focus more on what truly matters — patient care. As the technology continues to evolve and improve, its adoption will likely become more widespread, further enhancing its benefits. The post Evidence-Based Medicine: AI Scribes Actually Work appeared first on MedCity News.
Healthcare providers and vendors are learning the hard way that hackers are relentless and resourceful, constantly adjusting tactics and tools and using new technology, including AI, to launch more sophisticated attacks. The post Healthcare’s Cybersecurity Crisis: Why Today’s Defenses Are Failing Against Evolving Threats appeared first on MedCity News.
Carrum Health has expanded its value-based substance use program to include cannabis, sedatives and stimulants. The post Carrum Health Expands SUD Treatment Program to Include Nearly All Substances appeared first on MedCity News.
Currently available therapies for Hunter syndrome don’t cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denali’s Data in Rare Enzyme Deficiency Keep It on Pace…
From the FTC’s press release out today: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’…
This brief focuses on the stand-alone Medicare Part D prescription drug plan marketplace and its somewhat uncertain future, in light of recent trends in plan availability and the potential for another year of premium increases in 2026, in part depending on what the Trump administration decides to do with the temporary Part D premium stabilization…
Nearly 1 in 4 Medicaid enrollees are eligible for the program because they are ages 65 and older or have a disability, and they have higher per-enrollee costs than other enrollees. Proposals to limit federal spending on Medicaid may create incentives for states to drop or reduce their eligibility or coverage for seniors and people…